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According to the Annual Data Report of the United States
Renal Data System (USRDS) in 2004, Taiwan had the
highest incidence of end-stage renal disease (ESRD) and
the second highest prevalence globally [1]. This fact ap-
pears to underline the marked impact of the ESRD pop-
ulation on the health care budget in Taiwan, where less
than 0.2% of the total population on dialysis treatment
accounted for more than 7% of the total expenditure of
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Taiwan has the highest incidence and prevalence of end-stage renal disease worldwide. However,
not many studies have focused on the influence of dialysis modality on health-related quality of
life (HRQoL) for dialysis patients in Taiwan. This study intended to compare the differences in
HRQoL between peritoneal dialysis (PD) and hemodialysis (HD) and to evaluate the effects of
dialysis modality on patient HRQoL. A cross-sectional survey using the Taiwan-version 36-item
short-form health survey questionnaire (SF-36) was completed by 244 dialysis patients (58 PD and
186 HD patients) at two hospital-based dialysis units in southern Taiwan. Patient characteristics,
diagnoses and laboratory data were individually extracted from the annual survey and matched
with primary HRQoL data. Multiple linear regression analysis was performed to evaluate the effects
of dialysis modality on HRQoL. Compared with HD patients, PD patients had higher scores in
six of the eight SF-36 subscales, including physical functioning, role limitations due to physical and
emotional problems, bodily pain, vitality, and mental health. However, only role limitations due
to emotional problems and bodily pain reached significant difference levels (p<0.05). After control-
ling for patient characteristics, comorbid conditions and laboratory values, the bodily pain score
was 7.88 points higher for PD patients compared with HD patients, while the social functioning
score was 9.00 points higher for HD patients compared with PD patients (p < 0.05). The present
study provides cross-sectional confirmation for equivalent levels of HRQoL between PD and HD
patients except for the subscales of bodily pain and social functioning. In addition to dialysis
modality, HRQoL for dialysis patients may be more related to personal attributes, interactions with
multiple diseases, social support and quality of care received. When informing patients about
modality choices for dialysis, trade-offs should be discussed and individual preferences for specific
aspects of HRQoL should be considered.
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the National Health Insurance (NHI) program in 2002
[2]. Because of the increasing expense and resource
utilization for ESRD patients, most discussions have
focused on cost containment for dialysis-related ser-
vices. Few studies have focused on health-related
quality of life (HRQoL) for peritoneal dialysis (PD)
and hemodialysis (HD) patients in Taiwan.
HD is considered a high-volume and high-cost
treatment compared with PD. Overall, 96% of ESRD
patients use HD instead of PD (high-volume) and the
annual cost per person per year for HD is more than
30% higher than for PD (US$20,488 vs. US$15,295) in
Taiwan [3]. The issue of HRQoL for HD versus PD
patients is critical to future care planning and service
utilization because Taiwan’s NHI operates with a
global budget for dialysis treatments.
The importance of HRQoL in clinical research has
been extensively discussed over recent decades and
it is now widely accepted as an important indicator of
health care treatment outcomes [4]. Quality of life of
ESRD patients is influenced by the disease itself and
by the type of alternative therapies a patient receives.
Many studies on quality of life have been done on PD
and HD patients around the world, with empirical
evidence indicating that differences in HRQoL are
associated with PD and HD treatments [5–12]. No
consistent findings yet exist to show whether PD or
HD treatments are associated with better HRQoL.
Previous HRQoL studies of assessments of dialysis
patients in Taiwan have used self-developed research
instruments [13,14], which caused difficulties in mak-
ing cross-national comparisons. Recent studies using
the SF-36 or the QoL questionnaire developed by the
World Health Organization (WHOQoL) primarily
focused on HD patients [15,16] or PD patients [17].
The present study compared the differences in
HRQoL between PD and HD patients using the 36-
item short-form health survey questionnaire (SF-36),
Taiwan version, and examined the effects of dialysis
modality on HRQoL, adjusting for patient character-
istics, clinical diagnoses and laboratory variables.
METHODS
Sample and data sources
The study design consisted of a cross-sectional, 
face-to-face interview survey using the SF-36, Taiwan
version, on two hospital-based dialysis units, one in 
a university hospital and one in a municipal teaching
hospital, in Kaohsiung City. All registered dialysis
patients of the two hospitals were included in the
study (n = 244). All were stable dialysis patients who
had been on dialysis for more than 3 months during
the recruitment period. On average, the PD patients
(n = 58) had received dialysis treatment for 39 months
and the HD patients (n = 186) for 49 months.
Two sources of data were used for the study.
Primary data were collected by the SF-36 survey over
3 months in 2000. For corresponding patient charac-
teristics, clinical diagnoses and laboratory information,
data from the 2000 annual survey performed by the
Taiwan Society of Nephrology were used. Laboratory
data were collected within the time frame in which the
SF-36 survey took place. Patient characteristics, diag-
noses and laboratory data were individually extracted
and matched with the HRQoL data.
Measurement and study variables
The research instrument was the Taiwan version of
the 36-item short-form health survey questionnaire
(SF-36), which originated from the Medical Outcome
Study [18]. The SF-36 has been widely used and vali-
dated as a quality-of-life assessment instrument for
general populations and for patients with kidney dis-
eases cross-nationally [19–26].
The SF-36, Taiwan version, was developed by the
Laboratory of Health Databank and Center for Popu-
lation; the validity and reliability of the SF-36, Taiwan
version, has been thoroughly examined in a nation-
wide Health Survey Research study; item discrimi-
native validity and internal reliability have reached
acceptable levels [27]. Like the original SF-36, the
Taiwan version comprises eight subscales: physical
functioning (PF), role limitations due to physical prob-
lems (RP), role limitations due to emotional problems
(RE), social functioning (SF), bodily pain (BP), general
health (GH), vitality (VT), and mental health (MH). 
A total score ranging from 0 to 100 is calculated for
each domain, a higher score indicating a better quality-
of-life state in that domain. The scores for the eight
domains are further summarized into two measures:
the Physical Component Scale (PCS) and the Mental
Component Scale (MCS). The PCS and MCS scores are
also converted into a 0–100-point scale [18].
In addition to HRQoL assessment, three types of
study variables were derived from the Taiwan Society
of Nephrology data set: patient characteristics, clinical
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diagnoses and laboratory variables. Patient character-
istics included age, gender, marital status, educational
level and working status. Clinical diagnoses focused
on the primary cause of ESRD and patients’ chronic
conditions. The primary cause of ESRD was classified
as diabetes and non-diabetes. Several major chronic
diseases in ESRD patients were selected for the meas-
urement of comorbid conditions, including cardio-
vascular disease, renal osteodystrophy, liver disease,
gastrointestinal disease, nervous system disease,
pruritus and other systemic diseases. To consider the
SF-36 scores in relation to important clinical aspects
[28,29], the laboratory variables hematocrit, serum
albumin and Kt/Vurea, were included in the analyses.
Erythropoietin treatment and length of time on dialysis
were also considered. The laboratory data were col-
lected at the time of the SF-36 survey.
Statistical techniques
The distributions of patient characteristics, clinical
diagnoses and laboratory data were determined and
compared by dialysis modality using χ2 statistics for
the percentages of categorical variables or t statistics
for the means of continuous variables. Unadjusted
mean scores on the SF-36 subscales were compared
for PD and HD patients by t tests. Multiple linear
regression analysis was used to examine the effect of
dialysis modality on the mean scores of the eight SF-36
domains and the summary scores of the PCS and
MCS, adjusted for statistically significant factors that
were found in the descriptive comparison of PD and
HD patients, which included patient characteristics
(age, employment status, educational level), primary
cause of ESRD (diabetic vs. non-diabetic), laboratory
data (hematocrit level, albumin level), and erythro-
poietin treatment. The Kt/V value was excluded from
regression analysis because its estimation was different
between PD and HD patients.
RESULTS
Descriptions of patient characteristics and
chronic conditions
Table 1 shows the distributions of patient charac-
teristics, chronic conditions, and laboratory data by
dialysis modality. Compared with HD patients, PD
patients were significantly younger (p<0.05), and a
larger proportion of them were employed (p<0.001).
The distribution of education level was significantly
different between PD and HD patients (p<0.001). More
than 40% of HD patients only finished primary high
school compared with 20.7% of HD patients (p<0.001).
Table 1 also shows a significantly higher percent-
age of HD patients with diabetes as the primary cause
of ESRD (13.8% for PD vs. 31.2% for HD; p < 0.01).
There was no significant difference in the prevalence
of cardiovascular disease or other comorbidities be-
tween PD and HD patients. Mean hematocrit value
was higher for HD patients (p < 0.001), while the albu-
min serum level was higher in the PD group (p < 0.01).
The difference in the proportion of PD and HD
patients who received erythropoietin treatment also
reached the significant level (p < 0.01). Table 1 shows
the values of Kt/V for PD and HD patients; however,
no comparison of Kt/V values could be made because
of different time frames of data collection. All the sta-
tistically significant variables presented in Table 1 are
included in the multiple regression models in Table 2.
Comparison of SF-36 scores of PD and 
HD patients
Table 3 shows the mean scores (out of a possible 100)
for the eight subscales and the two components of
the SF-36 by dialysis modality. All scores for the eight
SF-36 subscales, except SF and GH, were higher in
PD than HD patients. No significant difference in the
scores was found between HD and PD patients except
on the RE and BP subscales. Compared with PD
patients, HD patients reported higher scores for RE
and BP (p < 0.05). The PCS and MCS scores were also
higher in PD patients compared with HD patients, but
differences were not statistically significant.
SF-36 scores of PD and HD patients
compared with the general population
The mean SF-36 subscale scores for the general popu-
lation are also provided in Table 3. In general, patients
receiving dialysis (PD and HD) reported lower scores
reflecting physical function (e.g. PF and RP). The
scores reflecting mental function (e.g. VT and MH)
tended to be similar to those observed in the general
population without kidney failure.
Comparison of PD and HD patients
between the US and Taiwan
We compared the present results to the study of 
Diaz-Buxo et al [11], as shown in the Figure. On the
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Table 1. Patient characteristics and chronic conditions of peritoneal dialysis (PD) and hemodialysis (HD) patients*
Variable PD (n = 58) HD (n = 186) p†
Age, yr 49 ± 13.4 53 ± 13 < 0.05
Male 22 (37.9) 82 (43.9) 0.332
Married 51 (87.9) 157 (84.4) 0.509
Employed 33 (56.9) 57 (30.6) < 0.001
Educational level
Primary school 12 (20.7) 86 (46.2) < 0.001
Elementary school 10 (17.2) 39 (21.0) NS
High school 24 (41.4) 47 (25.3) NS
College or above 12 (20.7) 14 (7.5) NS
Diabetes as primary cause 8 (13.8) 58 (31.2) < 0.01
Comorbidities
Cardiovascular disease 47 (81.0) 132 (71.0) 0.130
Renal osteodystrophy 0 8 (4.3) 0.108
Liver disease 0 7 (3.8) 0.134
Gastrointestinal disease 1 (1.7) 7 (3.8) 0.446
Nervous system disease 4 (6.9) 14 (7.5) 0.876
Pruritus and other systemic diseases 18 (31.0) 41 (22.0) 0.163
Number of comorbidities 1.2 ± 0.7 1.1 ± 0.7 0.436
Months of dialysis 39.4 ± 33.0 49.3 ± 51.4 0.086
Hematocrit, % 28.1 ± 3.5 30.0 ± 4.0 < 0.001
Albumin, g/dL 3.9 ± 0.3 3.8 ± 0.3 < 0.01
Kt/Vurea 2.0 ± 0.4 1.3 ± 0.2 ND
Treated with erythropoietin 44 (75.9) 167 (89.8) < 0.01
*Data presented as mean ± standard deviation or n (%); †Student’s t test for continuous variables and χ2 test for categorical variables,
with p < 0.05 considered statistically significant. NS = no significant difference between the two groups; ND = not determined.
Table 2. Regression analysis of subscales and physical and mental components of the SF-36 (n = 233)*
PF RP BP GH VT SF RE MH PCS MCS
Age −0.630† −0.206 −0.114 −0.295† −0.270† −0.239† −0.308 −0.160 −0.189† −0.065
Working status 6.035 3.594 8.514† 4.635 10.079† 5.196 2.642 4.271 3.907† 2.135
Ref.: unemployed
Education level −2.025 13.993† 4.882 0.673 1.455 −1.273 9.131 0.748 1.402 0.899
Ref.: less than high 
school 




Hematocrit level −0.565 0.014 0.302 −0.183 −0.061 0.051 0.649 −0.113 −0.118 0.100
Albumin level 17.797† 0.426 7.617 1.045 8.977 13.960† −16.906 5.416 6.006† −0.198
Treated with EPO −2.128 −2.921 9.677 −2.194 −0.982 −0.570 6.290 −2.970 0.200 −0.216
Dialysis modality 4.610 7.785 −7.880† 7.728 6.270 9.004† −13.811 0.981 3.074 −0.244
Ref.: peritoneal 
dialysis
Adjusted R2 (%) 37.1 10.5 12.6 10.0 16.2 17.6 3.7 8.2 28.0 2.1
*Each regression model was adjusted for age, gender, working status, education level, primary cause of diabetes mellitus, number of
comorbidities, hematocrit and albumin level; †p < 0.05. PF = physical functioning; RP = role limitations due to physical problems; BP =
bodily pain; GH = general health; VT = vitality; SF = social functioning; RE = role limitations due to emotional problems; MH = mental
health; PCS = Physical Component Scale; MCS = Mental Component Scale; Ref. = reference group for comparison; EPO = erythropoietin.
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physical subscales, the PF scores were similar between
PD and HD patients in Taiwanese and US samples.
However, PF scores of US PD and HD patients were
much lower than in the present study (44.8 vs. 71.37
for PD, 41.4 vs. 65.11 for HD, p < 0.05). The HRQoL
score for BP was very similar between US PD and HD
patients, but significantly different between Taiwanese
PD and HD patients (76.49 vs. 64.92, p < 0.05). On the
mental subscales, the SF and MH scores for PD and
HD patients in Taiwan were similar to the US scores.
The VT score for US PD patients was 42.30 compared
with 52.35 for Taiwanese PD patients. The significant
difference in role limitations due to mental health prob-
lems between Taiwanese PD and HD patients (58.17
vs. 42.67, p < 0.05) was not found in the US samples.
Regression analyses on HRQoL of 
dialysis patients
The results of multiple regression analysis for the
eight subscales and two components of the SF-36 are
presented in Table 2. After controlling for patient
characteristics, chronic conditions and laboratory data,
dialysis modality was significantly associated with BP
and SF. The score for BP was 7.88 points higher for PD
patients compared with HD patients, while the SF score
was 9.00 points higher for HD patients compared with
PD patients (p<0.05). Across the regression models for
each subscale, age and diabetes were associated with
several of the SF-36 scales. The model for PF had the
highest volume of variance explained (adjusted R2 =
37.1%) and PD patients scored higher for PF. However,
we found no significant difference in PCS between PD
and HD patients in the adjusted regression models.
DISCUSSION
HRQoL is considered to be an important indicator of
health care treatment outcomes. However, assessments
of HRQoL in ESRD patients are few and have mainly
focused on HD patients in Taiwan [14,15]. The present
study is one of the few HRQoL studies of dialysis
Table 3. Comparison of SF-36 scores between peritoneal dialysis (PD) and hemodialysis (HD) patients*
Subscale General population† PD (n = 51) HD (n = 182) p
Physical functioning (PF) 92.24 ± 16.16 71.37 ± 20.95 65.11 ± 28.84 0.087
Role-physical (RP) 83.65 ± 33.27 41.67 ± 39.58 39.84 ± 42.45 0.783
Bodily pain (BP) 84.84 ± 19.42 76.49 ± 22.72 64.92 ± 23.33 < 0.05
General health (GH) 69.29 ± 21.27 45.65 ± 22.79 48.12 ± 23.10 0.499
Vitality (VT) 68.27 ± 18.66 52.35 ± 22.86 51.76 ± 22.54 0.868
Social functioning (SF) 86.81 ± 17.05 63.97 ± 23.54 67.10 ± 21.84 0.375
Role-emotional (RE) 79.40 ± 36.07 58.17 ± 42.08 42.67 ± 43.95 < 0.05
Mental health (MH) 73.01 ± 16.55 64.78 ± 18.05 61.21 ± 19.34 0.238
Physical Component Scale (PCS) NA 41.75 ± 11.05 40.39 ± 12.26 0.476
Mental Component Scale (MCS) NA 43.84 ± 10.50 42.30 ± 10.61 0.360























Figure. SF-36 physical subscales of peritoneal dialysis (PD) and hemodialysis (HD) patients: a comparison of the present study and
US samples from the study of Diaz-Buxo et al [11]. Data are expressed as mean (95% confidence interval).
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patients that compares HRQoL between PD and HD
patients in Taiwan. According to the present find-
ings, PD patients scored higher in six of the eight sub-
scales of the SF-36. It seems that the selection of PD
may have benefits in terms of HRQoL. However, it
should be noted that HRQoL data are descriptive and
self-reported. Comparison of the results between PD
and HD patients needs to be interpreted cautiously.
Because only the differences in the mean scores for
RE and BP are significant between the PD and HD
patients, it is more reasonable to conclude that PD and
HD patients have equivalent levels of HRQoL [10,11].
In general, PD and HD patients in the US had
equivalent levels of HRQoL [11]. The crude significant
differences in the scores for BP and RE were not found
in the US samples. Compared with the US dialysis
samples of PD and HD patients, our study patients
had better HRQoL in the components of physical
health; however, the HRQoL in the components of
mental health was relatively lower. Of note, the com-
parison of the present study with the US samples is
still descriptive and the US HD sample had a higher
mean age, and included more males and more diabetic
patients [11]. Comparing our data to another HD sam-
ple in Taiwan [15], our HD sample is younger and has
better HRQoL in the PCS and MCS. However, our HD
sample has lower scores for the subscales of RE, RP
and BP. It might be possible that younger HD patients
tend to have higher expectation of role playing.
Adjusting for patient characteristics, primary cause
of ESRD and laboratory data, SF and BP became the
only two subscales that were significantly associated
with dialysis modalities. The SF score was 9 points
higher for HD compared with PD patients, which
might be because PD patients experienced greater
distress and isolation owing to a lack of social support
from similar patients and medical staff compared
with the in-center HD patients [10]. On the other hand,
BP score was 7.88 points lower for HD compared
with PD patients. As reported by Merkus et al for 
the NECOSAD Study group [20], PD patients may
see themselves as less physically impaired and self-
perceive a lower degree of BP.
In considering the BP subscale it is interesting to
note that working status is significantly associated with
the HRQoL score for BP, in addition to dialysis modal-
ity. Similar to the study by Blake et al in Ireland [21],
unemployed ESRD patients scored significantly lower
than employed patients for BP and VT in our study
sample. It is possible that maintaining working status
is one concern for ESRD patients in selecting a dialysis
modality. However, the design of our cross-sectional
study could not compare the direct and indirect effects
between dialysis modality and working status and
their effects on HRQoL in ESRD patients.
Independent of dialysis modality, physical, psy-
chologic and social functioning are highly interrelated
[5]. Most dialysis patients were selected for PD or HD
by their physicians based on diagnosis or comorbidity.
Consistent with previous studies, the present findings
indicate that dialysis patients with diabetes as the
primary cause of ESRD had significantly lower scores
on six subscales of the SF-36 [12]. Management and
care of dialysis patients with diabetes may be more
important than dialysis modality to improve the
HRQoL of such patients. Indeed, there is an interaction
effect of dialysis modality and diabetes on the HRQoL
of SF and BP (data not shown).
The present study is limited to a cross-sectional
study with a relatively small sample size. The results
on the effects of dialysis modality may not be fully
generalized to all dialysis patients in Taiwan. For
future research, a longitudinal study with a larger
sample size is suggested to extend the implications of
the findings and to examine the interrelationships
between dialysis modality and physical and psycho-
social functioning of chronic dialysis patients [29].
Aside from these findings, there are many other fac-
tors associated with HRQoL that we did not include
in our analyses, such as family support, health behav-
iors and socioeconomic status, which make cross-
national or cross-study comparisons difficult.
In conclusion, the present study provides cross-
national confirmation of equivalent levels of HRQoL
between PD and HD patients, except for the BP and
SF subscales. In addition to dialysis modality, HRQoL
for dialysis patients may be more related to personal
attributes, interactions of multiple diseases, social
support and quality of care received. When informing
patients about modality choices, trade-offs should be
discussed and individual preferences for specific
aspects of HRQoL should be considered.
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橫斷性研究調查南台灣某醫學中心及區域醫院之透析患者，總共有 244 位透析患者 
(腹膜透析 58 位、186 位血液透析患者 )。擷取病人一般特性、診斷、檢驗資料與健
康相關生活品質卷資料分析，以複線性回歸為分析方法。相較於血液透析患者，腹膜
透析患者在身體生理功能 (physical functioning、PF)、因身體生理問題角色受限 
(role limitation due to physical health problems、 RP)， 身 體 疼 痛 (bodily 
pain、BP)，活力狀況 (vitality、VT)，因情緒問題角色受限 (role limitation due 
to emotional problem、RE)，心理健康 (mental health、MH) 等六個指標的分數
較高，但只有身體疼痛與因情緒問題角色受限兩項達統計學上的意義 (p < 0.05)。在
控制其他變項後，選擇腹膜透析患者其身體疼痛的健康狀況評分高於血液透析患者 
7.88 分，但在社會功能 (social functioning、SF) 分數血液透析患者則高於腹膜透析
患者 9.00 分 (p < 0.05)。除身體疼痛與社會功能兩項指標外，腹膜透析與血液透析病
患其健康狀況相近。因此透析患者與健康相關之生活品質 , 除透析模式外，可能與透
析患者特質，合併症嚴重程度，家庭支持，與其接受照護之品質更加相關。因此透析
模式之選擇，患者應被告知不同透析模式之優缺點，並考慮透析患者之喜好。
關鍵詞：健康相關生活品質，血液透析，腹膜透析，SF-36
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